Paradigm Biopharmaceuticals
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
500 Collins St L 15, Melbourne, Victoria...Phone Number
+61 396295566Website
www.paradigmbiopharma.comRevenue
$5.1 MillionStock Symbol
PARIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
1
1
1
1
About Paradigm Biopharmaceuticals
Paradigm Biopharmaceuticals Ltd. is a late-stage drug development company focused on transforming underutilized molecules into effective treatments for significant unmet medical needs. The company collaborates with leading pharmaceutical development experts to leverage cutting-edge science and technology. Their portfolio includes treatments for osteoarthritis and various global diseases, aiming to reduce the time, cost, and risk associated with bringing new medications to market. Through their innovative approach, they offer new hope to patients and investment opportunities for stakeholders.Explore more
Paradigm Biopharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
KL
Director, Regulatory Affairs
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Paradigm Biopharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Paradigm Biopharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Paradigm Biopharmaceuticals
Check if Paradigm Biopharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Paradigm Biopharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Paradigm Biopharmaceuticals is spiking on competitors!
Product Launch: Get notified when Paradigm Biopharmaceuticals launches new products
Paradigm Biopharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Paradigm Biopharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Paradigm Biopharmaceuticals
Find more new buyers
Compare Similar Companies to Paradigm Biopharmaceuticals
Compare insights from companies similar to Paradigm Biopharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Paradigm Biopharmaceutica...
$5.1M
11-50
Public
$14M
2014
Abby Macnish NivenChief Financial Officer & Company Secretary
Company Profile Activity
Activity Insights
Paradigm Biopharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Paradigm Biopharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Paradigm Biopharmaceuticals.
Paradigm Biopharmaceuticals financials insights
Gather financial insights about Paradigm Biopharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Stock/Share Issuance
$14M
Paradigm Biopharmaceuticals Tech Stack
A closer look at the technologies used by Paradigm Biopharmaceuticals
See more technologies
Most Recent Scoops
Funding
Funding
Project
Laboratory Operations, Medical Research, Clinical Operations
Left Company
Executive Move
Left Company
Executive Move
Lateral Move
Executive Move
Paradigm Biopharmaceuticals News & Media
Paradigm raises $14 million as Phase 3 trial advances toward pivotal interim data
Managing director Paul Rennie said the level of investor support underscored confidence in the company’s Phase 3 program and its upcoming interim analysis.Paradigm Biopharmaceuticals raises $14M in upsized placement, launches SPP
Paradigm Biopharmaceuticals Ltd (ASX:PAR) has completed a $14 million placement and launched a share purchase plan (SPP) to raise up to a further $2 million, with funds to support its Phase 3 osteoarthritis trial through interim analysis and preparation for a potential New Drug Application...Paradigm Biopharmaceuticals Limited's (ASX:PAR) Profit Outlook
Paradigm Biopharmaceuticals Limited ( ASX:PAR ) is possibly approaching a major achievement in its business, so we...Paradigm Biopharmaceuticals Secures US$27 Million in Convertible Notes Agreement
The latest announcement is out from Paradigm Biopharmaceuticals ( ($AU:PAR) ). Paradigm Biopharmaceuticals has issued a cleansing notice related to the release of c...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Paradigm Biopharmaceuticals
Sign Up For FreeTo access detailed company insights
Paradigm Biopharmaceuticals Ltd. is a late-stage drug development company focused on transforming underutilized molecules into effective treatments for significant unmet medical needs. The company collaborates with leading pharmaceutical development experts to leverage cutting-edge science and technology. Their portfolio includes treatments for ost... Read More
